ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 933,59
-0,22%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Akers Biosciences Inc (AKER)

  7. Akers Biosciences Inc (AKER) Actualités

AKER

Akers Biosciences (AKER)

Akers Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AKER
DateHeureSourceTitreSymboleSociété
20/06/202323h01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:AKERAkers Biosciences Inc
10/06/202300h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AKERAkers Biosciences Inc
09/06/202322h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AKERAkers Biosciences Inc
31/03/202323h03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AKERAkers Biosciences Inc
13/03/202321h30Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AKERAkers Biosciences Inc
23/02/202315h01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:AKERAkers Biosciences Inc
14/02/202313h41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AKERAkers Biosciences Inc
10/11/202223h03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AKERAkers Biosciences Inc
26/10/202223h20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AKERAkers Biosciences Inc
08/09/202222h23Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:AKERAkers Biosciences Inc
30/08/202214h00Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:AKERAkers Biosciences Inc
05/07/202222h41Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AKERAkers Biosciences Inc
15/11/202122h54Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:AKERAkers Biosciences Inc
02/07/202122h01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AKERAkers Biosciences Inc
18/05/202112h07Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:AKERAkers Biosciences Inc
12/05/202112h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AKERAkers Biosciences Inc
11/05/202122h28Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:AKERAkers Biosciences Inc
29/04/202122h10GlobeNewswire Inc.Contango Announces the Appointment of Two New DirectorsNASDAQ:AKERAkers Biosciences Inc
28/04/202123h26Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:AKERAkers Biosciences Inc
21/04/202122h49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AKERAkers Biosciences Inc
16/04/202118h30Business WireAkers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of MergerNASDAQ:AKERAkers Biosciences Inc
13/04/202115h00Business WireAkers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression TrialNASDAQ:AKERAkers Biosciences Inc
12/04/202115h00Business WireAkers’ Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory BoardNASDAQ:AKERAkers Biosciences Inc
26/03/202100h37Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AKERAkers Biosciences Inc
22/03/202122h22Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:AKERAkers Biosciences Inc
22/03/202113h00Business WireAkers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD PharmaceuticalsNASDAQ:AKERAkers Biosciences Inc
19/03/202119h03Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:AKERAkers Biosciences Inc
23/02/202115h00Business WireMyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins DiscoveryNASDAQ:AKERAkers Biosciences Inc
18/02/202120h23Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AKERAkers Biosciences Inc
18/02/202115h00Business WireStudy Identifies Effects of Temperature Changes on SARS-CoV-2 TransmissionNASDAQ:AKERAkers Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:AKER

Dernières Valeurs Consultées

BIT
P1JU56
BNP Paribas Issuance
BIT
S30147
Societe Generale Effekten
COIN
PSWAPUST
Polkaswap
BIT
P1LSJ1
BNP Paribas Issuance
NYSE
PSPC.WS
Post Holdings Partnering
ASX
PNV
Polynovo
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés